Filing Details
- Accession Number:
- 0001209191-20-007523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-07 16:27:12
- Reporting Period:
- 2020-02-05
- Accepted Time:
- 2020-02-07 16:27:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-05 | 6,320 | $0.00 | 24,079 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-05 | 2,918 | $0.00 | 26,997 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-05 | 3,226 | $0.00 | 30,223 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2020-02-06 | 466 | $187.53 | 30,689 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-06 | 343 | $238.73 | 30,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 92 | $240.46 | 30,254 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-06 | 31 | $242.47 | 30,223 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-06 | 466 | $0.00 | 466 | $187.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,587 | 2029-02-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020.
- Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020.
- Restricted stock unit award that vests in installments beginning on 02/10/2021.
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $238.73 (range $238.15 to $239.14).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $240.46 (range $240.11 to $240.84).
- The option vests in 16 quarterly installments from 02/06/2019.
Billionaire Hedge Funds
